Regenxbio (RGNX) Net Margin (2016 - 2025)
Historic Net Margin for Regenxbio (RGNX) over the last 12 years, with Q3 2025 value amounting to 208.39%.
- Regenxbio's Net Margin rose 380100.0% to 208.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 110.38%, marking a year-over-year increase of 1731000.0%. This contributed to the annual value of 272.54% for FY2024, which is 194500.0% up from last year.
- Per Regenxbio's latest filing, its Net Margin stood at 208.39% for Q3 2025, which was up 380100.0% from 331.91% recorded in Q2 2025.
- In the past 5 years, Regenxbio's Net Margin registered a high of 73.75% during Q4 2021, and its lowest value of 405.63% during Q1 2024.
- Moreover, its 5-year median value for Net Margin was 246.4% (2024), whereas its average is 239.22%.
- Its Net Margin has fluctuated over the past 5 years, first plummeted by -2649600bps in 2022, then surged by 4124300bps in 2025.
- Over the past 5 years, Regenxbio's Net Margin (Quarter) stood at 73.75% in 2021, then tumbled by -359bps to 191.21% in 2022, then tumbled by -48bps to 283.8% in 2023, then rose by 15bps to 241.68% in 2024, then rose by 14bps to 208.39% in 2025.
- Its Net Margin stands at 208.39% for Q3 2025, versus 331.91% for Q2 2025 and 6.81% for Q1 2025.